Metastatic Colorectal Carcinoma (mCRC)
Oncology·MeSH: Colorectal Neoplasms
3 drugs in development·1 company·1 clinical trial
Drug Pipeline by Phase
Phase 3(1)
| Drug | Company |
|---|---|
| Fruquintinib | IGM Biosciences, Inc. (IGMS) |
Phase 2(2)
Compare drugs
Frequently asked questions
How many drugs are in development for Metastatic Colorectal Carcinoma (mCRC)?
BioSniper tracks 3 drugs in development for Metastatic Colorectal Carcinoma (mCRC) across 1 company.
How many clinical trials target Metastatic Colorectal Carcinoma (mCRC)?
There are 1 clinical trial targeting Metastatic Colorectal Carcinoma (mCRC) tracked by BioSniper.
Deep-dive into Metastatic Colorectal Carcinoma (mCRC)
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis